期刊
RHEUMATOLOGY
卷 52, 期 6, 页码 1018-1021出版社
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kes326
关键词
hyperuricaemia; CCL2; monocytes; inflammation; gout
类别
资金
- Arthritis New Zealand [R184]
- Health Research Council of New Zealand [06024]
- Henry Cotton Trust
- Wellington Medical Research Foundation [2011/203]
Objective. To investigate the effect of hyperuricaemia on serum chemokine (C-C motif) ligand 2 (CCL2) levels and blood monocytes in people with gout. Methods. Whole blood was collected from subjects with a history of acute or chronic gout but not currently experiencing an attack of gout, subjects with asymptomatic hyperuricaemia and healthy individuals with normouricaemia. Serum concentrations of CCL2 were measured by bead array and levels of CD14(+)/CD11b(+) blood monocytes determined by flow cytometry. Results. Subjects with gout and asymptomatic hyperuricaemia had higher serum levels of CCL2 and showed an increase in the percentage of circulating CD14(+) monocytes compared with subjects with normouricaemia. Conclusion. Hyperuricaemia causes elevated serum CCL2 levels and increased monocyte recruitment that may be driven by soluble uric acid-induced CCL2 production. Hyperuricaemia may initiate subclinical priming of circulating blood monocytes for adhesion and trafficking during a gout attack.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据